June 10, 2005
Ms. Anjali Nayyar has been appointed Vice President of Country & Regional Programmes at the not-for-profit International AIDS Vaccine Initiative (IAVI). She was previously the Country Director of IAVI India.
“Since its inception, IAVI has been committed to working with our partners in the developing world to enhance global awareness of the urgent need for a preventive AIDS vaccine,” said Seth F. Berkley, president and CEO, IAVI. “With her wealth of experience in India and passion for her work, we are confident Anjali will successfully lead the CRP in support of our organization’s overall mission.”
Anjali Nayyar has spent more than a decade in the advocacy and communications field, managing South and East Asia communications and advocacy activities at the Population Council, India. During this period she planned and coordinated several advocacy and communications projects on reproductive and sexual health issues. She also conducted numerous training programmes for researchers, government agencies and NGOs on reproductive and sexual health communications and developed information kits on emergency contraception and expanded, informed contraceptive choices. Some of these materials were subsequently mass produced by the Government of India for programme managers.
Among her many accomplishments at IAVI, Anjali provided strategic direction to the program in India and successfully launched the first AIDS vaccine trial in the country.
As Vice President of Country & Regional Programmes (CRP), Anjali will be responsible for the coordination and implementation of IAVI’s country offices programmes including advocacy and vaccine preparedness.
Anjali Nayyar has a master's degree in population studies (training in health communications) from Johns Hopkins University. She serves on the board of the International Partnership for Microbicides and has published several articles and papers on public health strategy, reproductive health and HIV vaccine preparedness.
About IAVI: IAVI (www.iavi.org) is a global not-for-profit organization working to accelerate the development of a vaccine to prevent HIV infection and AIDS. Founded in 1996 and operational in 23 countries, IAVI and its network of collaborators research and develop vaccine candidates. IAVI also works to assure that a vaccine will be accessible to everyone who needs it. IAVI’s major financial supporters include the Bill & Melinda Gates Foundation; the Rockefeller, Sloan and Starr foundations; the World Bank; BD (Becton, Dickinson & Co.); the European Union; and the governments of Canada, Denmark, Ireland, the Netherlands, Norway, Sweden, the United Kingdom and the United States.